Transportation & Mobility VC Funds

Nordic Alpha Partners (NAP) is a Copenhagen and Munich-based growth equity fund specializing in scaling industrial GreenTech companies. Established in 2017, NAP manages over €275 million across its funds, focusing on helping visionary founders expand their operations from local players to global leaders. The firm’s unique operational approach emphasizes active engagement, with partners working closely with portfolio companies for up to a year before formal investment. This de-risks ventures and supports rapid, capital-efficient growth. NAP's investment strategy is rooted in sustainability, specifically targeting “dark green” companies that contribute to the global green transition. NAP's impact is demonstrated by the abatement of over 1.1 million tonnes of CO2 and the creation of more than 700 jobs across its portfolio. Notable investments include AquaGreen, which revolutionizes biomass pyrolysis for energy and nutrient recovery, and Green Hydrogen Systems, a leader in the green hydrogen revolution. With strong backing from investors like Allianz Global Investors, Novo Holdings, and KfW Capital, NAP has emerged as a leader in the GreenTech space. Their approach is supported by an extensive value-creation toolkit, which guides companies through the complexities of scaling capital-intensive technologies. NAP also fosters future GreenTech leaders by collaborating with academic institutions, including the Technical University of Denmark. Committed to economic sustainability, NAP helps fuel the growth of next-generation companies that drive the global green transformation while ensuring long-term financial success for their investors.

Nordic Eye Venture Capital is a Danish venture and growth capital firm headquartered in Copenhagen, with additional presence in San Francisco and Zurich. Founded in 2016, Nordic Eye focuses on investing in early-growth companies within the tech and lifestyle sectors. The firm is known for its strategic investments in high-potential companies that have demonstrated product-market fit and scalability. Notable investments in their portfolio include MATE, a company revolutionizing the e-bike market; Bellabeat, a health tech company; and AirHelp, which assists air passengers in claiming compensation for delayed flights. Other significant investments are in companies like Blue Ocean Robotics, known for developing service robots, and Organic Basics, a sustainable fashion brand. Nordic Eye's investment strategy involves not just providing capital but also actively supporting their portfolio companies through their growth stages. They prefer to enter investments once a company has proven its product-market fit and aim to exit when the company has demonstrated its scalability​. The firm is committed to responsible investing, integrating Environmental, Social, and Governance (ESG) policies with their business strategy to ensure sustainable business practices that lead to long-term success​.

Nordic Makers, established in 2016, is an early-stage investment firm founded by a group of experienced angel investors from the Nordic region. The firm focuses on seed and early-stage investments, primarily in technology-driven startups across the Nordics and Europe. Their investment philosophy centers on providing founder-friendly terms and leveraging their extensive network to support entrepreneurial growth. Notable investments by Nordic Makers include Labster, a leading provider of virtual science labs; Seaborg Technologies, which is developing sustainable nuclear reactor technology; and NextMind, which creates brain-sensing wearable devices for real-time device control. Other significant investments include Willa Pay, Helix Nano, LetsBuild, Singa, and Climateview​. The firm’s founding partners, such as Klaus Nyengaard, Esben Gadsbøll, and Alexander Aghassipour, bring a wealth of experience from successful ventures like Just Eat, WhiteAway, and Zendesk. They focus on fostering cross-border investments and integrating the Nordic and Baltic startup ecosystems.

Noro-Moseley Partners is an Atlanta-based venture capital firm specializing in early growth equity investments, primarily in the healthcare and technology sectors. Established in 1983, the firm targets rapidly scaling companies with significant market disruption potential. Their typical investment size ranges from $5 million to $20 million, focusing on businesses that exhibit over 50% year-over-year growth and strong unit economics. Noro-Moseley Partners has an impressive track record, with exits generating over $4 billion in aggregate enterprise value since 2015. Their portfolio includes companies offering cutting-edge solutions, such as Red Canary, a leader in managed detection and response (MDR) services, and Revenue Analytics, which focuses on revenue management software. Their healthcare investments span various areas like infusion services and healthcare payment integrity platforms. The firm places a strong emphasis on partnering with exceptional management teams, offering not just capital but also strategic support. This hands-on approach is evident through their involvement in helping companies build boards with experienced operators and navigate transitions from service-based to SaaS models. By focusing on high-growth companies with the potential for market disruption, Noro-Moseley Partners continues to be a key player in the venture capital space, particularly in the Southeastern U.S. and beyond.

North Bridge Venture Partners, founded in 1994 and based in Wellesley, Massachusetts, is a venture capital firm that provides seed-to-growth financing. The firm focuses on several key sectors, including communications and infrastructure, software, materials, healthcare, and digital media. North Bridge Venture Partners supports companies from their initial stages through to becoming market leaders, leveraging a combination of operational experience and strategic guidance​. The firm has made over 479 investments and has achieved 183 exits. Notable portfolio companies include Couchbase, Markforged, and Lyra Therapeutics. North Bridge has a significant presence in the U.S. market, focusing primarily on early-stage and growth-stage companies operating in healthcare and information technology sectors​. North Bridge is led by a team of experienced professionals, including founder and managing partner Edward Anderson and general partners Richard D'Amore and Jeffrey McCarthy. The firm's strategy emphasizes investing in exceptional entrepreneurs whose ideas have the potential to disrupt their respective industries.

North First Ventures (N1V) is an Israeli early-stage venture capital fund founded in 2017 by Founder and Managing Partner Ronen Smooha. The firm is headquartered in the Midtown TLV Office Tower at 144 Menachem Begin Road in Tel Aviv. N1V partners with Israeli seed and Series A stage companies that harness innovative technologies to solve real-world problems within large existing markets or to create entirely new ones. The team draws on a mix of seasoned entrepreneurs, mentors, global business and marketing strategists, and deep technologists who have personally navigated the non-linear journey of building startups across multiple stages and industries. N1V has invested in approximately 12 companies across AI, SaaS, healthcare, cybersecurity, consumer, and commerce. Portfolio highlights include NoTraffic, a real-time traffic management platform using smart sensors to prepare road infrastructure for connected and autonomous vehicles; Cervello, a cybersecurity solution for railways and metro operational networks covering threat detection, asset management, and continuous monitoring; Octopai, an ML-based metadata discovery SaaS platform acquired by Cloudera in 2024; Veego; and Home365. The fund has produced two acquisitions to date — Octopai and Model 9, which was acquired by BMC. The firm's most recent first-time investment was Gaviti, and the most recent follow-on was NoTraffic. N1V positions its involvement as more than financial: the team works hands-on with founders to build business engines that scale, bringing the direct experience of investors who have lived through company-building at multiple stages. The fund is explicit that great technology must be paired with a strong go-to-market and organizational capability to create durable value.

North Island Ventures (NIV), founded in 2020 by Travis Scher, James Hutchins, and Glenn Hutchins, is a New York-based venture capital firm focused on investing in the crypto and Web3 space. NIV has approximately $300 million in assets under management and targets early-stage investments in companies developing innovative blockchain technologies and applications. Their portfolio includes notable investments in companies such as Axelar, BCB Group, Dapper Labs, Flow, ImmuneFi, and Polymer Labs. NIV's investment strategy centers on supporting emerging technologies that can create new applications and experiences, leveraging the unique capabilities of blockchain and crypto. NIV recently closed its second fund, NIV Fund II, with $125 million in commitments, aiming to make 30 to 40 investments with initial investments ranging from $250,000 to $3 million. The fund focuses on sectors like DeFi, NFTs, digital identity, blockchain cybersecurity, cross-chain interoperability, and decentralized science.

North Sky Capital is a pioneering impact investment firm, recognized for its deep commitment to sustainable investing. Established in 2000, the firm has been a trailblazer in the impact investment landscape, particularly through its two core strategies: impact secondaries and sustainable infrastructure. North Sky’s investments focus on sectors like climate tech, clean energy, sustainable food, and waste management, emphasizing both environmental and social impact alongside financial returns. Geographically, North Sky is predominantly active in developed markets, with investments across the United States, Canada, Europe, and beyond. They’ve deployed over $1.4 billion across more than 140 investments, with a particular emphasis on mid-market companies that contribute to the energy transition, circular economy, and healthy living sectors. The firm's strategy is distinctive for its leadership in the impact secondaries market—a niche within private equity where North Sky was the first to launch an impact-focused secondaries fund in 2013. Their latest fund, Clean Growth VI, raised $250 million, reflecting their ability to attract major institutional investors globally. The firm often leads these rounds, leveraging its extensive network to source high-impact opportunities that might be overlooked by traditional secondary funds. Key team members like CEO Scott Barrington and Managing Director Gretchen Postula are central to the firm’s success, combining decades of experience in private markets with a passionate commitment to sustainability. North Sky prefers to work closely with companies, often leading investment rounds and seeking partnerships that align with their rigorous impact criteria.

The North West Fund is a £155 million investment fund aimed at supporting small and medium-sized enterprises (SMEs) in the North West of England. Managed by North West Business Finance Limited, an independent private sector company, the fund was established to address gaps in lending, venture capital, and private equity markets. The fund has been fully invested, supporting over 443 businesses and creating more than 6,300 jobs in the region. The fund comprises several sub-funds, each managed by different fund managers, providing a range of financial support from equity investments to loans. These sub-funds include The North West Fund for Venture Capital, Mezzanine, Loans Plus, Micro Loans, Energy and Environmental, Biomedical, and Digital and Creative. These funds have been instrumental in facilitating the growth and expansion of innovative businesses across various sectors. The North West Fund has a strong team of experienced professionals, including Cliff Maylor (Chief Executive Officer), Neil Morrey (Chief Operating Officer), and Mike Kenyon (Chief Financial Officer). The fund's governance is supported by an independent Board and an Investment Advisory Panel with expertise in private equity, venture capital, and the targeted sectors.

Northstar Ventures is a UK-based venture capital firm focused on early-stage investments that create a positive social or environmental impact. With a portfolio that spans tech innovation and social enterprises, the firm emphasizes sectors like climate tech, biotech, and healthy aging. Their notable investments include Newcells Biotech, which develops in vitro organ models for drug testing, and NunaBio, a leader in DNA synthesis technology crucial for personalized medicine and data storage solutions​. Geographically, Northstar Ventures primarily focuses on startups in the North East of England but also supports businesses across the UK. They invest through funds such as the North East Innovation Fund and the Northstar EIS Growth Fund, with typical early-stage investments ranging from £300,000 to £1 million​. Their hands-on approach includes extensive support for founders, particularly in sectors that align with sustainability goals, like Low Carbon Materials, which develops environmentally friendly construction materials. Northstar also backs social impact ventures, such as Coping with Cancer North East, reflecting their commitment to community well-being alongside technological innovation.

Northzone, established in 1996, is a multi-stage venture capital fund investing in companies from Seed to Growth stages across Europe and the US. With a notable portfolio that includes companies like Spotify, Klarna, Trustpilot, and Kahoot!, Northzone has built a reputation for backing category-defining entrepreneurs. In 2022, Northzone raised €1 billion, emphasizing its commitment to supporting innovative startups that can thrive amidst global challenges. The firm’s investment strategy spans various sectors, including fintech, healthtech, SaaS, and consumer technology. Northzone typically writes checks between €1 million and €40 million, allowing them to support companies through multiple stages of growth, from initial funding to pre-IPO. Their approach is characterized by a focus on founders with conviction, a willingness to embrace risk, and a dedication to long-term partnerships. Northzone’s team operates across major cities like New York, London, Stockholm, Amsterdam, and Berlin, reflecting their "glocal" (global and local) mindset. This diverse and international team, comprising 36 members from 16 nationalities, brings a wealth of experience and a strong network to the table. The firm values integrity, results, intellectual curiosity, and strong partnerships, and has consistently championed diversity and inclusion both within their team and across their portfolio. Entrepreneurs interested in partnering with Northzone are encouraged to present bold ideas with substantial market potential. The firm values straightforward communication and prefers to invest in teams capable of navigating and thriving in challenging environments

Norwest Venture Partners (NVP), headquartered in Menlo Park, California, is a prominent venture capital and growth equity investment firm managing over $15.5 billion in capital. Founded in 1961, Norwest has invested in more than 700 companies across various sectors, including enterprise, consumer, and healthcare. Some of their notable investments include companies like Spotify, Adaptive Insights, Udemy, Talkspace, Opendoor, Kendra Scott, and Health Catalyst. These investments highlight Norwest's diversified approach, backing high-impact companies at various stages of growth from early to late-stage. Norwest recently announced the closing of its seventeenth fund, NVP 17, raising $3 billion to continue supporting visionary entrepreneurs. The firm operates globally with offices in Menlo Park, San Francisco, Mumbai, and Tel Aviv, focusing on North America, India, and Israel​. With a strong commitment to their portfolio companies, Norwest offers extensive support through their experienced investment and portfolio services teams, helping businesses navigate growth and scale effectively. This hands-on approach has contributed to their track record of successful exits and sustained growth in their portfolio companies​.

Not Boring Capital, founded by Packy McCormick, is a venture capital firm that emphasizes investing in innovative and transformative startups. Established in 2019 and based in New York City, the firm has made notable investments in various sectors, including fintech, health tech, and blockchain technology. The portfolio includes companies like Footprint, which offers identity and attribute verification solutions, and Disco, a platform for customer management solutions. Other significant investments include Gilded, providing accounting and payment solutions for crypto businesses, and Union54, which focuses on correspondent banking solutions in Zambia. Not Boring Capital typically invests in early-stage ventures, particularly in seed and Series A rounds. Recent investments include Unnatural Products, a biotech firm focused on molecularly targeted therapeutics, and Atomic AI, an AI-based platform for RNA drug discovery. The firm collaborates with prominent co-investors such as Index Ventures, Bessemer Venture Partners, and Andreessen Horowitz to support these startups. By leveraging a robust network and expertise in storytelling, Not Boring Capital aims to help its portfolio companies scale effectively and reach their full potential. The firm’s strategy includes not only financial investment but also strategic guidance and brand building.

Notation Capital, established in 2015 by Nicholas Chirls and Alex Lines, is a pioneering pre-seed venture capital firm based in Brooklyn, New York. Specializing in early-stage investments, Notation Capital supports technical teams at the inception of their business journeys, often at the idea stage. Notation's notable investments include Spruce, Livepeer, Bison Trails, and Parsec, showcasing their focus on hard tech, infrastructure, and product-centric startups. The fund is heavily focused on the New York City area but does not limit itself geographically if the opportunity aligns well with their investment philosophy. They typically lead the first round of financing with investment sizes ranging from $250K to $750K. Their strategy emphasizes deep involvement from day one, providing not just capital but also substantial operational support, leveraging their extensive network of advisors, founders, and LPs to accelerate growth and product development. Key team members include Nicholas Chirls, who brings expertise in product development and growth strategies from his previous role at betaworks, and Alex Lines, a seasoned software engineer with a decade of experience in building scalable products. Startups looking to engage with Notation Capital should demonstrate a strong technical foundation and a compelling vision for disruptive innovation. They prefer founders who are deeply product-focused and exhibit a strong determination to execute their vision.

Notion Capital, founded by seasoned SaaS entrepreneurs, excels in investing in early-stage European startups, particularly in SaaS and enterprise tech. With a strong operational background, they leverage deep industry knowledge to support portfolio companies like GoCardless, Paddle, and Mews. Their focus spans business software, fintech, and future finance sectors, targeting transformative technologies like AI and cloud computing. Geographically, Notion Capital is centered on Europe, emphasizing markets in the UK, Germany, and France. Their strategy involves providing significant support through a dedicated platform team, aiding in product development, go-to-market strategies, and talent acquisition. They employ advanced AI for investment sourcing, ensuring they stay ahead in identifying high-potential startups. The fund typically leads Series A rounds, with an average check size of around €15 million, maintaining a portfolio of about 20 core investments. Recent notable investments include Bound, DataOps, and Resistant AI. Founders benefit from Notion's extensive network and strategic guidance, fostering growth and scaling efficiently. Key team members include Stephen Chandler, Jos White, and Itxaso del Palacio, who bring extensive experience from their entrepreneurial and investment backgrounds. This diverse and dynamic team is committed to a hands-on approach, driving success and innovation within their portfolio companies. Overall, Notion Capital stands out for its founder-friendly approach, combining strategic insights with robust financial backing, making it a formidable player in the European venture capital landscape.

Novastar Ventures is one of Africa's largest and most established dedicated venture capital firms, founded in 2014 by Co-founders and Managing Partners Steve Beck and Andrew Carruthers. Headquartered in Nairobi, Kenya, with additional offices in Lagos, Nigeria and London — where Novastar Ventures Limited operates as an FCA-authorised entity — the firm runs a team of 10 across 4 partners. It has scaled across three vehicles: the East Africa Fund (Fund I), the Africa Fund II anchored by the European Investment Bank and British International Investment, and the new Africa People and Planet Fund III, which reached final close in early 2026 at $147 million and will for the first time deploy on a pan-African basis. Novastar leads rounds with an average cheque of approximately $1.5 million and a maximum of $5 million across seed, Series A, and Series B stages. The investment thesis is to back early- and growth-stage entrepreneurs building businesses that widen access, improve quality, and lower cost of basic goods and services for Africa's mass-market consumers — companies where positive social impact for low-income households is a natural by-product of commercial success. Sectors include e-mobility, agriculture, health tech, telecom, retail, energy, and fintech. Across 30 portfolio companies the fund has produced one unicorn: Moniepoint, a Nigerian fintech that achieved unicorn status in 2024 three years after Novastar's first cheque. Other standout portfolio names include Komaza, Africa's largest tree planter targeting one billion trees by 2030; BasiGo, an electric-bus Pay-as-you-Drive platform in East Africa; and Chowdeck. Novastar's pan-African expansion in Fund III, backed by institutional partners including Mitsui O.S.K. Lines, marks a significant broadening of geographic scope from its East and West Africa origins.

Novo Holdings is a premier life sciences investment firm based in Copenhagen, Denmark, with additional offices in Boston, San Francisco, London, and Singapore. The firm is wholly owned by the Novo Nordisk Foundation and manages an extensive portfolio aimed at generating long-term returns while advancing health and sustainability. Novo Holdings focuses on investments across biotechnology, medical technology, and digital health sectors, supporting companies at various stages, from early development to commercial phases. In 2023, the firm deployed DKK 3.6 billion, including significant investments in 4D Molecular, Alentis Therapeutics, and Lexeo Therapeutics. The firm's strategy emphasizes innovation in patient care and strong financial returns. Notably, Novo Holdings operates with an evergreen fund structure, allowing a long-term perspective on its investments. The firm actively engages with portfolio companies, often taking board positions to leverage its vast network and expertise. The investment team, led by Managing Partner Scott Beardsley, comprises professionals across major life science hubs. Key team members include Amit Kakar, Head of Novo Holdings Asia, and Anna Fan, Senior Partner in the Life Sciences Operating Committee. For startups seeking investment, Novo Holdings values groundbreaking science and robust clinical data, favoring companies with late preclinical or clinical stage compounds in biotech, and commercial stage entities in medtech and digital health

Nucleus Capital, founded in 2020 and based in Berlin, Germany, is a venture capital firm dedicated to supporting early-stage, purpose-driven entrepreneurs tackling systemic challenges to planetary health. They focus on three main sectors: programmable biology, food technology, and green industrials. Notable investments by Nucleus Capital include Yuri, a space biotech company; Planet A Foods, which develops biotech-derived food ingredients; and Hier Foods, a digital platform for food distribution. Other key investments encompass innovative startups like Farmless, which transforms renewable energy into food, and Brineworks, which focuses on ocean-based CO2 removal through electrochemistry​. Nucleus Capital typically invests in pre-seed and seed stages with check sizes ranging from €150k to €1 million. They aim to partner with mission-driven teams possessing deep domain expertise and creative solutions to global environmental challenges​​. The firm is led by co-founders Maximilian Schwarz and Isabella Fandrych, who bring significant expertise and a strong commitment to fostering entrepreneurial innovation for planetary health​.

NXTP Ventures, headquartered in Buenos Aires, is a leading venture capital firm in Latin America, focusing on early-stage tech startups. Their portfolio includes high-growth companies like Auth0, Nuvemshop, and Satellogic. With over 130 investments and numerous successful exits, NXTP is known for supporting innovative ventures in SaaS, logistics, and fintech sectors. They typically invest in Seed and Series A rounds, writing checks between $500k and $2 million. NXTP's strategy involves deep engagement with their portfolio companies, providing not just capital but also operational support, strategic guidance, and access to an extensive network of industry specialists and mentors. This approach has helped many of their investments achieve significant growth and market presence​ . The firm’s key team members, such as co-founder Ariel Arrieta, bring a wealth of experience in both investing and operating within the tech ecosystem. NXTP's investments are spread across Latin America, with a strong presence in Brazil, Argentina, Mexico, Chile, and Colombia.

Nyca Partners is a prominent venture capital firm that focuses on financial technology (fintech) investments. Established in 2014 and based in New York, Nyca Partners has over $870 million in assets under management. The firm invests across various stages, from seed to growth, with a particular emphasis on early-stage companies. Nyca's portfolio includes over 100 companies, with significant investments in well-known fintech startups such as Acorns, Affirm, and Revolut. Their investment strategy leverages their deep fintech expertise to connect innovative companies with the global financial system, fostering growth and scalability. Geographically, Nyca primarily invests in the U.S. but also considers global opportunities selectively. The firm’s approach is hands-on, providing active engagement and support to portfolio companies through strategic guidance and leveraging their extensive network. The team at Nyca Partners includes experienced professionals from leading financial institutions and fintech startups. Key team members include Hans Morris, Managing Partner, who brings a wealth of experience from his previous roles at Visa and Citigroup, and Ravi Mohan, Partner and COO, who has a strong background in financial services. Nyca's investment philosophy focuses on identifying transformative fintech solutions that can address critical needs in the financial sector. They seek out startups with innovative business models and strong growth potential, providing them with not only capital but also strategic support to help them succeed.

Nysnø Climate Investments is a state-owned Norwegian venture capital fund focused on advancing climate solutions through smart, profitable investments. Established in 2017 and based in Stavanger, Nysnø targets companies and technologies that directly contribute to reducing greenhouse gas emissions. The fund invests across sectors such as renewable energy, battery technology, offshore wind, and sustainable materials, supporting companies in their growth and commercialization phases. Nysnø has made significant strides in the green industry, with notable investments in companies like Morrow Batteries, a leader in sustainable battery production, and Vårgrønn, which develops offshore wind projects. The fund also emphasizes the importance of building new green value chains and has recently expanded into international investments, including participation in ArcTern Ventures II, a cleantech fund with a focus on North America and Europe. Primarily investing in companies linked to Norway, Nysnø also places a strong focus on long-term profitability, ensuring that its investments yield both financial returns and substantial environmental benefits. Through its portfolio, Nysnø has contributed to the growth of over 185 companies, helping to accelerate the green transition while creating positive societal impacts.

NZVC (New Zealand Venture Capital) is a Christchurch-based early-stage venture capital firm, uniquely positioned as New Zealand’s first operator-run fund. Founded by Mark Pavlyukovskyy, Ajay Gupta, and Glen Anderson, NZVC focuses on investing in promising Kiwi startups, particularly at the pre-seed to Series A stages. The firm was launched with a strong belief in New Zealand's untapped potential, viewing the country as a future hub for global innovation, especially in a post-COVID world where remote work has become the norm. NZVC has successfully raised an initial $10 million, with plans to reach $15 million, to invest in sectors such as B2B SaaS, deep tech, fintech, and web3/cryptocurrency. The fund supports startups with more than just capital, offering expertise in areas like AI/ML, product development, fundraising, and marketing. Their mission is to help founders scale their companies globally, leveraging a network of Silicon Valley connections and local expertise. Some of their notable investments include companies like Seachange, which is innovating in hydrofoiling and electric car ferries, and Pyper Vision, which is developing fog-clearing drones for airports. NZVC’s investment philosophy emphasizes working closely with founders to navigate the challenges of building high-growth companies from New Zealand.

Oak Investment Partners is a leading multi-stage venture capital firm that focuses on high-growth opportunities across several sectors, including information technology, financial services technology, healthcare, and clean energy. Founded in 1978, Oak has invested over $9 billion in more than 525 companies worldwide. The firm is known for its hands-on approach, offering comprehensive support and strategic assistance through its extensive network of industry experts. Oak's portfolio includes notable companies such as Castlight Health, Zayo Group, Kayak, Benefitfocus, and Protean Electric, among others. Their investment strategy spans early to late-stage investments, including growth equity and PIPE (private investment in public equity) investments. Oak Investment Partners has built a reputation for its ability to identify transformative opportunities and support them through long-term, steady guidance​. The firm is headquartered in Norwalk, Connecticut, with additional offices in California. The team includes experienced professionals like Managing Partners Bandel Carano, Ed Glassmeyer, Fred Harman, and Ann Lamont, who bring deep domain expertise and a consistent investment philosophy to the table​.

Obvious Ventures, founded in 2014 and based in San Francisco, is a venture capital firm focused on early and growth-stage investments. The firm emphasizes investments that align with their "world positive" approach, targeting sectors like planetary health, human health, and economic health. This mission-driven investment strategy seeks to support companies that create a positive impact on the world while generating significant financial returns. Notable investments by Obvious Ventures include Beyond Meat, Medable, and Dexterity. Beyond Meat, known for its plant-based meat products, went public in 2019, marking a significant milestone for the firm. Medable provides a cloud-based platform for decentralized clinical trials, while Dexterity develops AI-driven robotic systems for managing warehouses. Obvious Ventures has a diverse portfolio of over 130 companies, with successful exits including Recursion Pharmaceuticals, Lilium, and Proterra. The firm's portfolio spans various industries such as AI, biotech, fintech, and sustainable consumer goods. The team at Obvious Ventures includes co-founders Ev Williams, James Joaquin, and Vishal Vasishth, who bring extensive experience in entrepreneurship and venture capital. They are committed to supporting visionary founders who are building transformative companies.

OCA Ventures, based in Chicago, is an early-stage venture capital firm that has been investing since 1999. The firm primarily targets technology, financial services, education, and healthcare technology sectors. Their investment strategy focuses on Seed, Series A, and Series B rounds, with typical initial investments ranging from $1 to $4 million. They often lead the rounds in which they participate. Notable companies in their portfolio include SpotHero, a parking app; Base CRM, a cloud-based customer relationship management software; Pangea, an online money transfer service; and Cleversafe, a cloud-based data storage system. Other significant investments include dv01, LogicGate, and Placer.ai. OCA Ventures is also known for its OCA EDGE program, which invests $50,000 to $200,000 in seed rounds of about $1.5 million or less. This program is designed to support early-stage startups with potential for dramatic growth. The firm has a strong track record of successful exits, including the sale of Cleversafe to IBM and the IPO of Marqeta. Led by CEO Jim Dugan and co-founders John Dugan and Peter Ianello, OCA Ventures leverages a robust network of strategic relationships to support their portfolio companies and drive their growth.

OCBC Bank, headquartered in Singapore, is one of Southeast Asia’s largest financial services groups, with a comprehensive presence across the ASEAN region and Greater China. The bank's strategic vision revolves around a "One Group" approach, which integrates its various business units to offer seamless services across its extensive network in these regions. This strategy is designed to capitalize on the rising wealth in Asia and the growing trade flows between ASEAN and Greater China. As part of its corporate strategy, OCBC has been focusing on four key growth priorities: enhancing wealth management capabilities, increasing market share in regional trade, unlocking value in high-growth industries, and driving the transition to a low-carbon economy. The bank's recent performance has been strong, with net profits reaching record levels in 2024, driven by solid growth in wealth management and insurance income. To further support its strategic goals, OCBC has formed a new division called Group Strategy, Innovation, and Sustainability. This division is tasked with identifying new growth engines and driving the bank's sustainability agenda, ensuring that OCBC remains competitive and relevant in the rapidly changing financial landscape​.

Oceanpine Capital, founded in 2016, is a growth equity investment firm with offices in Beijing, Hong Kong, and Silicon Valley. The firm focuses on investing in disruptive technologies within sectors such as semiconductors, AI, 5G, IoT, big data, enterprise software, and biotech. Oceanpine aims to build long-term partnerships with visionary entrepreneurs to develop world-class companies. Oceanpine Capital has raised significant funds, including a $400 million debut fund and another $400 million for Fund II. The firm has invested over $1 billion across more than 40 companies in China and the US. Notable portfolio companies include Enflame Technology, Ansun Biopharma, Horizon Robotics, Black Sesame, and TigerGraph. Oceanpine's investment strategy emphasizes DeepTech and innovative growth companies, aligning with their commitment to fostering advancements in technology and healthcare sectors​.

Octopus Ventures, established in 2007 and headquartered in London, is a major venture capital firm in Europe with over £1.2 billion in assets under management. The firm invests in a diverse range of sectors, including B2B software, health tech, fintech, deep tech, consumer, climate, and bio. Their notable investments include well-known companies such as SwiftKey, ManyPets (formerly known as Bought By Many), Zoopla, LoveFilm, and Graze. Octopus Ventures focuses on supporting startups from pre-seed through to Series A and beyond, providing both funding and hands-on support to help companies scale. The firm is committed to backing founders with purpose-driven missions, emphasizing positive impact on people, communities, and the environment. Octopus Ventures employs a strategy that prioritizes long-term relationships with founders and deep sector expertise. They are particularly focused on disruptive technologies and innovative solutions that address significant global challenges. Recent investments reflect their commitment to sustainability and tech innovation, including companies like Token in fintech, Elliptic in blockchain analytics, and Minimum in climate tech. Led by a team of experienced investors and industry experts, Octopus Ventures ensures their portfolio companies receive the strategic guidance and operational support necessary for growth. The firm continues to expand its influence globally, aiming to foster innovation and drive positive change in the venture capital landscape.

OCV Partners is a Los Angeles-based venture capital firm, established with a mission to invest in companies that demonstrate significant growth potential, primarily in the technology and healthcare sectors. Their investment strategy is focused on mid- to late-stage companies, often in fields such as SaaS, fintech, biotech, and digital health. With a portfolio that includes innovative firms like Jukin Media, Scopely, and TaskUs, OCV Partners has positioned itself as a hands-on investor, providing both capital and operational support to help scale high-growth companies​. The firm prides itself on its diverse expertise, backing founders through every phase of their business journey. The OCV team brings decades of experience in building and scaling companies across various industries, from software and financial services to healthcare and media. They partner with startups not just to provide financial backing, but also to offer operational insight, helping businesses navigate the complexities of scaling. OCV Partners is well-known for its long-term mindset, focusing on building sustainable value through innovation and strong partnerships. The firm typically invests in companies at the seed to Series B stages, though they remain flexible and open to later-stage opportunities when appropriate.

Okapi Venture Capital, established in 2005 and based in Newport Beach, California, focuses on seed and early-stage investments in the information technology and life sciences sectors. The firm has made 83 investments and has 18 notable exits, including companies like Welltok, Qualaroo, and CrowdStrike. Their portfolio includes a diverse range of companies such as Occuspace, which provides smart building solutions, Trellis Research in legal tech, and Daasity, which offers eCommerce analytics solutions. Other significant investments include Babylist, an online discovery platform for baby products, and ChromaCode, which uses data science for advanced molecular diagnostics. Okapi's investment strategy emphasizes supporting innovative startups with high growth potential, often leading seed and Series A rounds. The team is led by co-founders Marc Averitt and Sharon Stevenson, alongside partners like Jeff Bocan and John Waller, who bring extensive experience in venture capital and technology management. The firm is particularly active in the US market and collaborates with co-investors such as SaaS Ventures, Mucker Capital, and Stage Venture Partners, to foster the growth and success of its portfolio companies.

Olive Tree Capital is a dynamic venture capital firm headquartered in Boston, Massachusetts, focusing on early-stage investments across various tech-driven sectors. Notable investments include Uber, Postmates, and Lark, illustrating their keen eye for potential high-growth startups. With a strong portfolio in Artificial Intelligence, Machine Learning, Health & Wellness, and Big Data & Analytics, Olive Tree Capital seeks to back transformative companies from pre-seed through Series A stages. Their investment strategy is characterized by flexibility and an evergreen capital structure, allowing them to lead rounds and provide significant follow-on funding without the constraints of traditional fund timelines. This approach facilitates a long-term partnership with startups, aiming for substantial growth and successful exits, as demonstrated by their involvement in high-profile mergers and acquisitions like those of Bueno Finance and 10 Minute Squad. The firm’s geographic focus extends primarily across the United States, with a pronounced presence in the Boston area. Key team members, including Managing Partners Nichola Eliovits and Yamen Al-Hajjar, bring extensive experience in technology and biotechnology, reinforcing the firm's industry expertise and strategic guidance. Olive Tree Capital’s investment process emphasizes rigorous due diligence and a collaborative approach with co-investors like Y Combinator and Soma Capital. Startups seeking to engage with Olive Tree Capital are encouraged to present a compelling vision for innovation and market disruption, aligning with the firm’s commitment to transformative impact and sustainable growth​.

OMERS Ventures, the venture capital arm of the Ontario Municipal Employees' Retirement System, focuses on investing in Series A to C companies across North America. Founded in 2011, the firm has backed several high-profile tech companies like Shopify and Wave. Their investment strategy centers on transformative technology sectors, including fintech, healthtech, proptech, and workplace technology. Typical initial investments range from $5 million to $25 million. OMERS Ventures has decided to withdraw from the European market to concentrate its efforts on North America. This strategic shift follows a challenging market environment in Europe and aims to leverage North America's relative economic stability. As part of this transition, the firm plans to open a new office in New York while maintaining its presence in Toronto and San Francisco. The leadership team includes Michael Yang, who emphasizes the importance of building strong relationships with founders and has a background in investing in emerging areas such as healthtech and IoT. For startups looking to engage with OMERS Ventures, demonstrating a deep understanding of the market and a clear vision for growth is essential. The firm values transparency and strong founder-investor relationships, aiming to support companies through various market challenges and opportunities.

Omidyar Technology Ventures (OTV) is a Silicon Valley-based venture capital firm founded in 2015 and launched publicly in 2016 by Pierre Omidyar, the billionaire founder of eBay. Headquartered in Redwood City, California, OTV operates as a single-LP family office-style vehicle — created and solely funded by Pierre Omidyar's personal capital — and is distinct from the better-known Omidyar Network, his 2004 philanthropic and impact investment platform. OTV is positioned as 'an entrepreneur's fund' and invests in a relatively concentrated portfolio at the early and growth stages in enterprise software, artificial intelligence and big data, financial technology, and online marketplaces. Because OTV deploys from Pierre Omidyar's balance sheet rather than a committed fund, it does not disclose AUM and can hold positions over very long time horizons, following on aggressively into later rounds without typical fund-lifecycle constraints. Across roughly 17 investments, OTV has produced three unicorns: Fundbox, an AI-based SMB lending platform; project44, a supply-chain visibility company that raised an $80 million Series G with OTV participation, led by Generation Investment Management and A.P. Moller Holding; and Phenom, a talent experience management platform. Recent portfolio exits include Convoy, acquired by DAT Solutions in July 2025, and Writable, acquired in February 2024. OTV's concentrated approach — a small number of high-conviction bets with patient capital and the personal brand of eBay's founder behind each investment — creates a distinct value proposition for founders seeking a long-term, low-friction institutional partner at the growth stage.

Omnes Capital is a leading European private equity firm specializing in energy transition and innovation. Founded in 1999 and based in Paris, Omnes manages over €5 billion in assets. The firm's investment strategy focuses on four core areas: renewable energy, sustainable cities, deep tech venture capital, and co-investment. Notable investments include Direct Energie, Neoen, and BioSerenity. Omnes has made significant strides in the renewable energy sector with its Capenergie funds, which have invested over €2.5 billion across more than 60 projects in Europe, transforming developers into independent power producers. For example, their Capenergie 2 fund achieved a 15% net IRR, ranking among the top performers in Europe. Omnes also plays a crucial role in sustainable urban development by financing projects that support decarbonization and resilient city infrastructure. Their deep tech investments focus on disruptive technologies and startups pushing the boundaries of innovation. In addition to financial returns, Omnes is committed to responsible investment practices. The firm supports non-profits through the Omnes Foundation, which focuses on education, health, and social integration for children. Omnes is also a signatory of the United Nations Principles for Responsible Investment (PRI), underscoring their commitment to sustainability and ethical investment​.

Omnivore is a leading venture capital firm based in India, focusing on early-stage investments in agritech and food systems. Founded in 2010 by Mark Kahn and Jinesh Shah, Omnivore aims to transform the agricultural sector by supporting startups that enhance productivity, sustainability, and profitability for smallholder farmers and rural communities. The firm’s investment themes include farmer platforms, fintech, B2B agri marketplaces, farm-to-consumer brands, precision agriculture, and post-harvest technologies​. Omnivore's portfolio features notable companies like DeHaat, BharatAgri, and Ecozen, which address critical challenges in the agriculture sector through innovative solutions. The firm recently closed the first round of its third fund, the Omnivore Agritech and Climate Sustainability Fund, with $150 million, aiming to support 25-30 new startups focused on climate-smart agriculture and agrifood life sciences​. Omnivore is also recognized for its significant impact on smallholder farmers, having created substantial economic value and improved agricultural practices across India. The firm has reached over 11.4 million smallholder farmers, enabled $1.44 billion in economic value, and facilitated loans and insurance coverage worth billions​. The investment team, led by Mark Kahn and Jinesh Shah, includes experienced partners and advisors deeply embedded in the agritech ecosystem. Their strategic investments are aimed at generating both financial returns and positive social impact​.

OMRON Ventures Co., Ltd. is the corporate venture capital arm of OMRON Corporation — Japan's TSE-listed industrial automation and healthcare technology conglomerate — founded in July 2014 and headquartered in Minato-ku, Tokyo. The firm exists to create innovation driven by social needs by investing in and jointly developing with startups worldwide whose original technologies address OMRON's priority social challenges. Thematic focus areas span factory automation and industrial IoT, smart cities, digital and connected-health wearables, mobility, and energy management. OMRON Ventures operates two successive funds: OVC 1st Fund from 2014, which invested in approximately 20 startups across factory automation, healthcare, and smart cities; and OVC 2nd Fund established January 2022, which was certified by Japan's Ministry of Economy, Trade and Industry as the first Japanese corporate venture fund exempted from overseas-investment regulations — enabling expanded global deployment. Cumulative fund size across both funds is approximately JPY 15 billion, or roughly $100 million. Across 22 disclosed investments, portfolio companies include LIGHTz, a Skill Transfer AI company for manufacturing that received a Series A investment in May 2025; Sky Labs, a wearable cardiac monitoring company backed in November 2025; HQ Inc.; and avatarin Inc., both invested in February 2025. Vice President Christina Connelly leads the firm's international engagement. OMRON's corporate heritage runs deep: founder Kazuma Tateishi established Kyoto Enterprise Development in 1972, widely regarded as Japan's oldest private venture capital firm. This institutional history, combined with OMRON's active manufacturing and healthcare operations across Asia, the US, and Europe, gives its venture arm privileged visibility into frontier industrial and healthcare technology as a customer, collaborator, and investor simultaneously.

OneVentures is a leading Australian venture capital firm with a global focus, investing in technology and healthcare companies. The firm provides both equity and credit funding, with a particular emphasis on innovative products addressing significant market needs. OneVentures operates through several funds. Their Growth Fund V, which closed at $142 million, focuses on technology and tech-enabled companies, investing up to $20 million per company. This fund targets global themes such as remote work, digitization, clean energy, and healthcare. Additionally, the firm manages the Growth Credit Fund IV and the VGF Credit Fund, providing debt financing to high-growth tech companies, with investments ranging from $500,000 to $10 million per company. In the healthcare sector, OneVentures manages the $170 million Healthcare Fund III, investing in therapeutics, devices, and diagnostics with a clear commercial pathway. This fund is part of the Commonwealth Government’s Biomedical Translation Fund program, aiming to advance promising biomedical innovations. OneVentures' portfolio includes companies like Vaxxas, which develops needle-free vaccine delivery technology, and BiVACOR, known for its artificial heart technology. The firm is known for its hands-on approach, providing strategic guidance and leveraging its extensive network to support the growth and success of its portfolio companies.

One Way Ventures, founded in 2017 and headquartered in Boston, Massachusetts, is a venture capital firm dedicated to investing in immigrant founders. The firm focuses on seed-stage and early-stage companies across various sectors, including logistics, mobility, fintech, proptech, deep tech, consumer technology, healthcare, AI, machine learning, and robotics. Notable investments by One Way Ventures include Brex, Chipper Cash, Classtag, and Momentus. The firm has made significant exits, such as Legalpad, acquired in 2022, and Lynk, a satellite communications company​. The portfolio is diverse, featuring companies like Beacon, an AI-powered workflow automation platform for logistics; Brelyon, a deep tech company creating virtual screens; and Care Academy, a caregiver training platform. Co-founded by Semyon Dukach and Eveline Buchatskiy, One Way Ventures aims to support high-impact global companies driven by the unique perspectives and experiences of immigrant founders. The firm values equal opportunity and the collective potential of humankind, striving to eliminate borders as barriers to innovation and growth​.

OneRagtime is a venture capital platform that focuses on sourcing, financing, and scaling early-stage tech startups across Europe. Founded by Stéphanie Hospital and Jean-Marie Messier, the firm offers a unique investment model that combines flexibility with a fully digitized process, allowing investors to choose how they invest, either through deal-by-deal or via their funds like OneRagtime Rhapsody II and OneRagtime Paragon. The firm invests primarily in seed and Series A stages, with initial investments ranging from €0.5 million to €3 million, and can follow up with investments up to €10 million. OneRagtime targets startups in several sectors, including consumer platforms (gaming, marketplaces, social media, and the creator economy), artificial intelligence, cloud services, cybersecurity, and tech for social good (education, climate, and health). Notable portfolio companies include Groover, an artist promotion platform; PhantomBuster, a no-code data automation tool; and Benefiz, an HR tech platform for managing employee benefits. OneRagtime also emphasizes providing strategic, operational, and business development support to its portfolio companies to ensure their growth and success. With a community-driven approach, OneRagtime offers investors the opportunity to engage deeply with startups, providing not just capital but also expertise and networks to drive innovation and growth in the tech sector.

Open Opportunity Fund is a venture and growth investment firm backing B2B software companies across Enterprise IT, Fintech, and People Ops. We focus on business-critical software fueled by cloud, AI, and agentic systems, with 70% of our portfolio companies based in emerging tech hubs across the U.S. in regions often overlooked by traditional VC. Fund I was a $100M vehicle and on the strength of that success, we are now raising Fund II. Our strategy combines early and growth-stage investing to back category-defining companies that transform how organizations manage infrastructure, streamline financial operations, and empower their workforces. The firm was founded by Paul Judge and Marcelo Claure, successful entrepreneurs who have each built and scaled companies to successful exits.

OpenSpace Ventures is a prominent venture capital firm based in Southeast Asia, known for its strategic investments in transformative tech companies across the region. Established in 2014, OpenSpace Ventures has backed notable companies like Gojek, Halodoc, and Love, Bonito, which have made significant impacts in their respective industries. The firm focuses on sectors such as fintech, healthcare, e-commerce, and digital media. Their portfolio includes companies like Lista, a financial management platform for individuals and small business owners in the Philippines; Lucence, a precision oncology company; and Nutrition Technologies, which produces sustainable insect-based proteins for agriculture. OpenSpace Ventures employs a hands-on approach, providing not only capital but also strategic guidance and operational support to help their portfolio companies scale and succeed. They manage several funds, including those focused on Series A/B and mid-stage growth investments, and are recognized for their deep expertise and active involvement in the Southeast Asian startup ecosystem​.

OpenView Venture Partners, based in Boston, is a leading venture capital firm focused on expansion-stage B2B software companies. Founded in 2006 by Scott Maxwell, OpenView specializes in product-led growth (PLG), backing high-potential startups in sectors like SaaS, cloud computing, and productivity software. Notable investments include companies like Calendly, Expensify, and UserTesting, which have scaled into industry leaders with the firm’s support. OpenView typically invests between $5 million and $15 million, focusing on companies with $2 million to $20 million in revenue. Their strategy revolves around more than just capital; they provide operational expertise, assisting with areas like pricing, go-to-market strategy, and talent acquisition. Their value-add model means they work closely with portfolio companies to optimize growth and operational efficiency, helping founders build sustainable and scalable businesses. Geographically, OpenView invests primarily in North America, with a keen eye for businesses that are ready to transition from early traction to full-scale market dominance. The firm is known for its deep expertise in the enterprise software space and is selective about partnering with companies that align with its product-led growth thesis. The leadership team, including key partners like Blake Bartlett and John McCullough, are hands-on with portfolio companies, often playing a pivotal role in key hires and strategic decisions. OpenView is particularly known for its content and community efforts, offering valuable industry insights and resources to help software leaders grow faster.

Opera Tech Ventures is a Paris-based venture capital firm launched in 2018 as the investment arm of BNP Paribas. Specializing in fintech, insurtech, AI, sustainability tech, and enterprise software, Opera Tech Ventures targets startups with cutting-edge solutions in these sectors. They predominantly invest in Series A to D rounds, with a focus on scalable technologies that address critical market needs. The firm typically invests between $3 million and $15 million per deal, often taking a leadership role in the funding process. Their portfolio includes companies like SESAMm, an AI-driven analytics firm, Stoik in cloud security, and Arbol in commercial insurance. With a global scope, Opera Tech Ventures invests across Europe and North America, particularly favoring markets in France, the UK, the US, and the Netherlands. Their investment strategy is driven by a deep understanding of fintech and enterprise solutions, looking for startups that can revolutionize industries and show strong growth potential. Co-investing with well-known partners like Andreessen Horowitz and Munich Re Ventures, Opera Tech Ventures ensures their portfolio companies receive both capital and strategic guidance​. Under the leadership of Thibaut Schlaeppi, the firm is highly engaged in supporting portfolio companies beyond just financial backing. They offer insights, mentorship, and extensive connections across industries. Their diverse team brings expertise from multiple sectors, allowing them to help companies scale effectively in highly competitive markets. By focusing on innovation, Opera Tech Ventures continues to build a robust portfolio of future-leading companies.

Operator Partners is a venture capital firm that uniquely operates with its own capital, investing in technology companies from the pre-seed to Series B stages. Founded and led by experienced entrepreneurs, the firm provides support beyond financial investment, focusing on helping companies with business building and scaling challenges that arise between board meetings. Operator Partners has a hands-on approach, offering guidance based on their own entrepreneurial experiences. They engage with founders on various aspects such as product development, customer acquisition, fundraising, recruiting, and establishing organizational culture. The firm does not lead funding rounds or take board seats but assists in finding lead investors if needed. The team includes General Partners Amit Avner, Gil Shklarski, Nat Turner, and Zach Weinberg, along with Partner Olivia Benjamin. This team brings extensive expertise from founding and scaling successful companies themselves, making them well-equipped to support their portfolio companies effectively.

OrbiMed is a leading healthcare-focused investment firm based in New York City, established in 1989. It manages over $18 billion in assets across various investment strategies, including public equity, private equity, and private credit/royalty investments. OrbiMed invests globally in companies spanning the healthcare sector, from biopharmaceuticals to medical devices and healthcare services. OrbiMed’s portfolio includes notable companies like Guardant Health, Adaptive Biotechnologies, and Apollomics, showcasing its strong presence in the biotech and medical device sectors. The firm is known for its ability to back innovative startups and has been instrumental in bringing over 60 new healthcare therapies to market​ ​. For startups and established companies looking to connect with OrbiMed, it is beneficial to demonstrate innovative healthcare solutions with strong potential for market impact. The firm typically leads investment rounds and provides significant strategic support to help companies grow into market leaders.

Origin Ventures is an early-stage venture capital firm based in Chicago, Illinois, founded in 1999 by Steve Miller and Bruce Barron. The firm focuses on investing in high-growth software, marketplace, and consumer businesses that are shaping the Digital Native Economy. Origin Ventures has a strong track record, having raised over $300 million across multiple funds and achieving notable exits with companies like Grubhub, Cameo, Fountain, and Tock​. The firm recently closed its fifth fund at $130 million, exceeding their initial target despite the challenges posed by the COVID-19 pandemic. This new fund continues to emphasize investments in the Digital Native Economy, targeting themes such as the workplace of the future, the creator economy, and the circular economy. Recent investments from this fund include companies like Blueboard, Vivrelle, Veho, Lumanu, and Everee. Origin Ventures operates with a thesis-driven approach and maintains a presence in all four continental U.S. time zones, with offices in Chicago, Salt Lake City, San Francisco, and Washington, D.C. This geographic diversity allows them to be close to elite teams and investment opportunities across North America​. The firm prides itself on its hands-on partnership with founders, offering extensive support from their experienced team of former entrepreneurs, operators, and engineers. This commitment has helped them build a portfolio of companies that have consistently delivered strong returns and defined new market categories.

Oriza Ventures is a venture capital fund that focuses on early-stage technology investments, primarily in North America. Founded by seasoned entrepreneurs and investors, Oriza Ventures supports startups with disruptive technological pursuits and innovative business ideas. The firm's portfolio spans various industries, including artificial intelligence, big data, Internet of Things, consumer internet, and medical and health products. The team at Oriza Ventures includes founding partners John Yu, Alex Liang, and Yao Xiao, who bring extensive experience in venture capital and entrepreneurship. They leverage their backgrounds to provide strategic guidance and resources to their portfolio companies. Oriza Ventures' portfolio features a diverse range of companies such as Ayla Networks, an IoT platform for smart home appliances; Bolt, an online checkout platform; and InterVenn Biosciences, which uses AI-driven mass spectrometry for medical applications.

Orkla Ventures is the venture capital arm of Orkla Group, a leading supplier of branded consumer goods based in Oslo, Norway. This corporate venture fund focuses on technology, digital platforms, and software solutions with a particular interest in digital health, sustainability, food tech, and SaaS solutions. Orkla Ventures aims to leverage its industry expertise to invest in innovative startups that align with Orkla’s business domains and strategic interests. Orkla Ventures typically invests in seed and early-stage companies, with a commitment to fostering growth and supporting innovative solutions. The firm has made significant investments, including in the medical chatbot service Your.MD, which helps ease the burden on healthcare systems by providing pre-primary care and digital health solutions​.

OS Fund, established in 2014 by Bryan Johnson, is a venture capital firm that invests in early-stage science and technology companies. The firm focuses on sectors such as genomics, synthetic biology, computationally derived therapeutics, advanced materials, and diagnostics. The goal is to support companies that are developing groundbreaking technologies and solutions to solve significant real-world challenges​. Bryan Johnson, who co-founded the fund, initially invested $100 million of his own money after selling his previous company, Braintree, to PayPal for $800 million. The fund seeks out entrepreneurs who are future-oriented and possess the ambition to create a better future for humanity​. OS Fund has a strong portfolio, including companies like Ginkgo Bioworks, Atomwise, and Verge Genomics. These companies are at the forefront of innovation, working on projects such as self-fertilizing crops, storing data in DNA, and designing new proteins.

Osage Venture Partners (OVP) is a Philadelphia-based venture capital firm that specializes in early-stage investments in B2B software companies. The firm primarily focuses on companies driving innovation in the future of work and education sectors. Since its inception, OVP has invested in over 30 companies, with a strong preference for those with recurring revenue models and deep domain expertise. Notable investments in their portfolio include companies like Sidecar, RiskLens, and ExecOnline. OVP typically invests in post-revenue companies with a revenue run rate between $500,000 and $3 million, focusing mainly on Seed and Series A rounds. They have a hands-on approach, often leading or co-leading investments and joining the boards of their portfolio companies. OVP emphasizes the importance of partnerships, leveraging their extensive network of technology executives and industry experts to support the growth and success of the companies they invest in. Their team is comprised of seasoned investors and former operators who provide strategic guidance and operational support to entrepreneurs.